Login
Login

WHY WE
NEED YOU

“ We want to stop women dying from metastatic breast cancer. With your support we can make even bigger steps forward. Thank you so much for giving so kindly. It is a wise investment. ”

– Prof Alexander Swarbrick, NBCF-funded researcher


Your support will fund urgent research to...

PREVENT

Prevent breast cancer through precision prevention.

DETECT

Detect breast cancer as early as possible and before it progresses. 

STOP

Stop the progression and recurrence of breast cancer.

TREAT

More effectively treat hard-to-treat and metastatic breast cancers.


The funds you raise are vital. The more you raise, the closer we get to our vision of Zero Deaths from breast cancer.

Could support researchers to develop new therapies for hard-to-treat breast cancers

Could support researchers to uncover more targeted and personalised treatments with fewer side-effects.

Could support researchers to develop a simple blood test to predict, detect and monitor the return and spread of breast cancer.

WHERE YOUR MONEY GOES

When you support the National Breast Cancer Foundation (NBCF), you’re supporting world-class research of outstanding scientific quality and potential to contribute towards NBCF’s vision of Zero Deaths from breast cancer. 

These projects are funded in meritorious order via NBCF’s independent and rigorous review system. NBCF funds ground-breaking research focussed on better understanding how to prevent and detect breast cancer early, how to stop the progression and recurrence of breast cancer and how to effectively treat hard-to-treat and metastatic breast cancers – research that ultimately save lives.  

PROFESSOR LAURA MACKAY

University of Melbourne

Project name: Resident memory T cells as targets for breast cancer immunotherapy  

Immunotherapy has emerged as an effective way to destroy tumour cells by boosting the body’s own immune system to target and eliminate tumours. Professor Laura Mackay will investigate a novel approach of eradicating cancer cells by enhancing a specific population of immune cells to improve immunotherapy for triple negative breast cancer, which currently faces limited effective treatment options.


PROFESSOR PAUL JAMES

Peter McCallum Cancer Centre 

Project name: Understanding the collective influence of genetic variants on breast cancer risk.  

Women with a high polygenic score, which is a combined measure of genetic variations, have over three times the risk of developing breast cancer. Professor Paul James aims to define the biological mechanisms by which a high polygenic risk score promotes cancer development and a low polygenic risk score provides protection.  

ABOUT THE NATIONAL BREAST CANCER FOUNDATION

The National Breast Cancer Foundation (NBCF) is Australia’s leading national body funding world-class breast cancer research towards our vision of Zero Deaths from breast cancer. 

Since our inception in 1994, NBCF has invested over $200M into more than 600 world-class research projects across Australia.

In this time, death rates from breast cancer in Australia have improved by 43%.

We've seen remarkable results, but the job's not done.

At NBCF, we're determined to create a better tomorrow. We know research matters, and it is central and critical to improving breast cancer outcomes.

That's why we fund the very best breast cancer research in Australia by awarding grants via an open national, competitive and rigorous peer review process.

Call us on 1300 803 551

Email us